Back to recall look-up

Recall archive

94,355 stored notices, from Jun 20, 2012 to Sep 23, 2026.

80 recalls · page 1 of 4

Drugs

Reported Dec 17, 2025

Varenicline Tablets, 1mg, 56 Tablets, Rx only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540, Made in…

Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.

Dr. Reddy's Laboratories, Inc.

Matched: Brand · Product · Product detailsSub potent drug: during the 9-month stability test conducted, the assay value for the affected lot was below specification limit.

FDA (openFDA drug enforcement)

Drugs

Reported Oct 15, 2025

Succinylcholine Chloride Injection, USP, 200 mg/10 mL (20 mg/mL), 25 x 10 mL Multiple-Dose Vials, For Intravenous or…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Dr. Reddy's Laboratories, Inc.

Matched: Brand · Product detailsOut-of-Specification (OOS) result during the 6-month stability testing; decreased preservative concentration.

FDA (openFDA drug enforcement)

Drugs

Reported Jul 23, 2025

Omeprazole Delayed-release Capsules, USP, 20mg, 1000-count bottle, Rx Only, Manufactured by: Dr. Reddy's Laboratories

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Dr. Reddy's Laboratories, Inc.

Matched: Brand · Product · Product detailsPresence of foreign tablets/capsules: presence of foreign Divalproex Sodium Extended-Release 250mg tablet in a bottle of omeprazole capsules.

FDA (openFDA drug enforcement)

Drugs

Reported Apr 23, 2025

Levetiracetam 0.75% in Sodium Chloride Injection 1,000 mg/100 mL (10 mg/mL), 1 x 100mL, Rx Only, Manufactured by: Gland…

High riskUsing this product could cause serious injury, illness or death — stop using it now.

Dr. Reddy's Laboratories, Inc.

Matched: Brand · Product detailsLABELING: LABEL MIX-UP: The infusion bag is incorrectly labeled as Levetiracetam in 0.82% Sodium Chloride Injection 500 mg/100 mL, while the aluminum…

FDA (openFDA drug enforcement)

Drugs

Reported Dec 18, 2024

Javygtor (sapropterin dihydrochloride) Tablets 100mg, 120-count bottle, Rx Only, Distributor: Dr. Reddy's Laboratories

Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.

Dr. Reddy's Laboratories, Inc.

Matched: Brand · Product · Product detailsFailed Impurities/Degradation Specifications

FDA (openFDA drug enforcement)

Drugs

Reported Nov 27, 2024

IBU (ibuprofen) 600 mg tablets, 500-count bottle, Rx Only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ…

Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.

Dr. Reddy's Laboratories, Inc.

Matched: Brand · Product · Product detailsFailed Tablet/Capsule Specifications

FDA (openFDA drug enforcement)

Drugs

Reported Nov 13, 2024

Morphine Sulfate Extended-Release Tablets 15 mg, 100-count per bottle, Rx Only, Manufactured by Mayne Pharma,…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Dr. Reddy's Laboratories, Inc.

Matched: BrandFailed Impurities/Degradation Specification

1 more product in this recall

FDA (openFDA drug enforcement)

Drugs

Reported Nov 6, 2024

Cinacalcet Tablets, 30 mg, 30-count bottle, Rx Only, Dr. Reddy's Laboratories Inc, Princeton, NJ 08540, Made in India,…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Dr. Reddy's Laboratories, Inc.

Matched: Brand · Product · Product detailsCGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit

2 more products in this recall

FDA (openFDA drug enforcement)

Drugs

Reported Sep 4, 2024

IBU Ibuprofen Tablets, USP, 800 mg, Rx Only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540, Made in…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Dr. Reddy's Laboratories, Inc.

Matched: Brand · Product · Product detailsFailed impurities/degradation specifications: results for unknown impurity, were 0.13% and 0.11% respectively, exceeding the 0.10% specification…

2 more products in this recall

FDA (openFDA drug enforcement)

Drugs

Reported Aug 14, 2024

Sevelamer Carbonate for Oral Suspension 0.8g packets, packaged in 90 packets per container, Distributor: Dr. Reddy's…

Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.

Dr. Reddy's Laboratories, Inc.

Matched: Brand · Product · Product detailsLabeling: Incorrect or Missing Lot and/or Exp Date. Missing lot number and expiration dates on packets

FDA (openFDA drug enforcement)

Drugs

Reported Jul 10, 2024

Eszopiclone Tablets, USP 1mg CIV, 30-count bottle, Rx only, Mfd. By: Dr. Reddy's Laboratories Limited, Bachupally - 500…

Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.

Dr. Reddy's Laboratories, Inc.

Matched: Brand · Product · Product detailsFailed Impurities/Degradation Specifications: Related Substances

1 more product in this recall

FDA (openFDA drug enforcement)

Drugs

Reported Jun 5, 2024

Zoledronic Acid Injection 5mg/100mL Sterile Solution, 100mL Single-Dose vials, Rx only, Distributor: Dr. Reddy's…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Dr. Reddy's Laboratories, Inc.

Matched: Brand · Product · Product detailsLack of Assurance of Sterility: Leaking vials

FDA (openFDA drug enforcement)

Drugs

Reported May 29, 2024

Sirolimus Tablets 1mg Tablets 100-count bottle, Rx Only, Distributed by: Dr. Reddy's Laboratories Inc., Princeton, NJ…

Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.

Dr. Reddy's Laboratories, Inc.

Matched: Brand · Product · Product detailsFailed Impurities/Degradation Specifications

FDA (openFDA drug enforcement)

Drugs

Reported May 15, 2024

Javygtor (sapropterin dihydrochloride) Powder for Oral Solution 100mg, 30 individual packets per carton, Rx Only,…

High riskUsing this product could cause serious injury, illness or death — stop using it now.

Dr. Reddy's Laboratories, Inc.

Matched: Brand · Product detailsSub-potent Drug; powder discoloration associated with decreased potency

1 more product in this recall

FDA (openFDA drug enforcement)

Drugs

Reported Feb 14, 2024

Glimepiride Tablets, USP 1mg, 100-count bottles, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Srikakulam-532 409…

Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.

Dr. Reddy's Laboratories, Inc.

Matched: Brand · Product · Product detailsMisprint on tablet

1 more product in this recall

FDA (openFDA drug enforcement)

Drugs

Reported Jan 17, 2024

Tacrolimus Capsules, USP 1mg, 100-Count Bottles, Rx Only, Manufactured by: Dr. Reddy's Laboratories Limited,…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Dr. Reddy's Laboratories, Inc.

Matched: Brand · Product · Product detailsPresence of Foreign Tablets/Capsules: One 0.5 mg Tacrolimus capsule found in a bottle of 1 mg Tacrolimus capsules.

1 more product in this recall

FDA (openFDA drug enforcement)

Drugs

Reported Nov 15, 2023

Montelukast Sodium Tablets, USP 10 mg, Rx Only, 1000 count bottle, Distributed by: Dr. Reddy's Laboratories.,…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Dr. Reddy's Laboratories, Inc.

Matched: Brand · Product · Product detailsPresence of Foreign Tablet(s)/Capsule(s): A foreign tablet was found in a bottle of Montelukast Sodium Tablets, USP 10mg, identified as metoprolol 25…

FDA (openFDA drug enforcement)

Drugs

Reported Jul 12, 2023

Tizanidine Tablets, USP, 4 mg, 100 Tablets (10 tablets x 10 unit dose blister packs) per carton, Rx Only, Packaged and…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Amerisource Health Services LLC

Matched: Reason for recallFailed Dissolution Specifications: this repackaged product was recalled by the manufacturer, Dr. Reddy's Laboratories, Inc., due to out of…

FDA (openFDA drug enforcement)

Drugs

Reported Mar 1, 2023

Tacrolimus Capsules, USP, 0.5 mg, 100-count bottle, Rx Only, Mfd. by Dr. Reddy's Laboratories Limited, Bachupally - 500…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Dr. Reddy's Laboratories, Inc.

Matched: Brand · Product · Product detailsPresence of Foreign Tablets/Capsules: Presence of one Tacrolimus 1 mg capsule co-mingled in a bottle containing and labeled as Tacrolimus 0.5 mg…

FDA (openFDA drug enforcement)

Drugs

Reported Dec 7, 2022

Allergy Relief D, Fexofenadine HCL 60mg/Antihistamine, Pseudoephedrine HCL 120mg/Nasal Decongestant, Extended-Release…

Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.

Dr. Reddy's Laboratories, Inc.

Matched: BrandFailed dissolution specifications

FDA (openFDA drug enforcement)

Drugs

Reported Oct 12, 2022

Phytonadione Injectable Emulsion USP, 10 mg/mL, 25x 1 mL single dose ampules per carton, Rx only, Distributed by: Dr.…

Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.

Dr. Reddy's Laboratories, Inc.

Matched: Brand · Product · Product detailsFailed Stability Specifications: Out of specification results reported at 12-month stability testing for aluminum content.

FDA (openFDA drug enforcement)

Drugs

Reported Aug 3, 2022

Lansoprazole Delayed-Release Orally Disintegrating Tablets, 15 mg, 100-count blisters per carton, 10 Packs of 10…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Dr. Reddy's Laboratories, Inc.

Matched: Brand · Product detailsFAILED DISSOLUTION SPECIFICATIONS

1 more product in this recall

FDA (openFDA drug enforcement)

Drugs

Reported May 11, 2022

Lansoprazole Delayed-Release Orally Disintegrating Tablets, 30 mg, 10 Packs of 10 Tablets each, 100 Tablets per blister…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Dr. Reddy's Laboratories, Inc.

Matched: Brand · Product detailsFailed Dissolution Specifications

FDA (openFDA drug enforcement)

Drugs

Reported Apr 6, 2022

Atorvstatin Calcium Tablets, USP 80 mg*, 90 Tablets, Rx Only, Mrd. By: Dr. Reddy's Laboratories Limited, Srikakulam -…

Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.

Dr. Reddy's Laboratories, Inc.

Matched: Brand · Product · Product detailsFailed Impurities/Degradation Specifications: Out of Specification results for related substance.

2 more products in this recall

FDA (openFDA drug enforcement)

RecallNow is not a government agency. Every notice above is published by the FDA, USDA FSIS, or CPSC and links back to its source. Back to the look-up